🇪🇸 UMECLIDINIUM BROMIDE in Spain

UMECLIDINIUM BROMIDE (UMECLIDINIUM BROMIDE) regulatory status in Spain.

Marketing authorisation

AEMPS

  • Local brand name: Incruse Ellipta (previously Incruse)
  • Status: approved

UMECLIDINIUM BROMIDE in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is UMECLIDINIUM BROMIDE approved in Spain?

Yes. AEMPS has authorised it.

Who is the marketing authorisation holder for UMECLIDINIUM BROMIDE in Spain?

Marketing authorisation holder not available in our data.